Search research articles
Contact Us
Filters
Showing results (251-260 of 293) with videos related to
Page
of 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2013
Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel
Anne M Noonan, Robin A Eisch, David J Liewehr, et al.
Blood
|
March 28, 2013
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
Arup R Chakraborty, Robert W Robey, Victoria L Luchenko, et al.
Cancer Research
|
March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines
Wanqing Liu, Xiaolin Wu, Wei Zhang, et al.
Journal of Clinical Pharmacology
|
August 28, 2015
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer
Andrew K L Goey, Tristan M Sissung, Cody J Peer, et al.
Biochemical Pharmacology
|
December 9, 2008
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Phase I trial of a new schedule of romidepsin in patients with advanced cancers
Laleh Amiri-Kordestani, Victoria Luchenko, Cody J Peer, et al.
Seminars in Oncology
|
November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
Harshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer
Ronan J Kelly, Deborah Draper, Clara C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
The role of breast cancer resistance protein in acute lymphoblastic leukemia
Sabine L A Plasschaert, Dorina M van der Kolk, Eveline S J M de Bont, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 293) with videos related to
Sort By:
Page
of 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2013
Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel
Anne M Noonan, Robin A Eisch, David J Liewehr, et al.
Blood
|
March 28, 2013
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
Arup R Chakraborty, Robert W Robey, Victoria L Luchenko, et al.
Cancer Research
|
March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines
Wanqing Liu, Xiaolin Wu, Wei Zhang, et al.
Journal of Clinical Pharmacology
|
August 28, 2015
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer
Andrew K L Goey, Tristan M Sissung, Cody J Peer, et al.
Biochemical Pharmacology
|
December 9, 2008
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Phase I trial of a new schedule of romidepsin in patients with advanced cancers
Laleh Amiri-Kordestani, Victoria Luchenko, Cody J Peer, et al.
Seminars in Oncology
|
November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
Harshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer
Ronan J Kelly, Deborah Draper, Clara C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
The role of breast cancer resistance protein in acute lymphoblastic leukemia
Sabine L A Plasschaert, Dorina M van der Kolk, Eveline S J M de Bont, et al.
Page
of 30